Cargando…
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation
Intravesical instillation of bacillus Calmette–Guérin (BCG) is used to treat superficial bladder cancer, either papillary tumors (after transurethral resection) or high-grade flat carcinomas (carcinoma in situ), reducing recurrence in about 70% of patients. Initially, BCG was proposed to work throug...
Autores principales: | García-Cuesta, Eva María, López-Cobo, Sheila, Álvarez-Maestro, Mario, Esteso, Gloria, Romera-Cárdenas, Gema, Rey, Mercedes, Cassady-Cain, Robin L., Linares, Ana, Valés-Gómez, Alejandro, Reyburn, Hugh Thomson, Martínez-Piñeiro, Luis, Valés-Gómez, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459093/ https://www.ncbi.nlm.nih.gov/pubmed/26106390 http://dx.doi.org/10.3389/fimmu.2015.00284 |
Ejemplares similares
-
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro
por: Esteso, Gloria, et al.
Publicado: (2022) -
Ionomycin Treatment Renders NK Cells Hyporesponsive
por: Romera-Cárdenas, Gema, et al.
Publicado: (2016) -
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients
por: Castellano, Eva, et al.
Publicado: (2022) -
Human NKG2D-ligands: cell biology strategies to ensure immune recognition
por: Fernández-Messina, Lola, et al.
Publicado: (2012) -
NKG2H-Expressing T Cells Negatively Regulate Immune Responses
por: Dukovska, Daniela, et al.
Publicado: (2018)